查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1545565

恒溫核酸增幅技術（INAAT）的全球市場

Isothermal Nucleic Acid Amplification Technology (INAAT)
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 179 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

預計到 2030 年全球等恒溫核酸增幅技術 (INAAT) 市場將達到 67 億美元

恒溫核酸增幅技術 (INAAT) 的全球市場預計 2023 年為 34 億美元，預計到 2030 年將達到 67 億美元，2023 年至 2030 年複合年成長率為 10.3%。 INAAT 試劑是本報告分析的細分市場之一，預計複合年成長率為 10.1%，到分析期結束時將達到 46 億美元。分析期間內，INAAT 設備領域的複合年成長率預計為 10.7%。

美國市場預估為8.983億美元，中國預期複合年成長率為9.7%

預計2023年美國恒溫核酸增幅技術（INAAT）市場規模為8.983億美元。中國作為全球第二大經濟體，預計2030年市場規模將達10億美元，2023-2030年分析期間複合年成長率為9.7%。其他值得注意的區域市場包括日本和加拿大，在分析期間預計複合年成長率分別為 9.2% 和 8.6%。在歐洲，德國的複合年成長率預計約為 8.0%。

全球恒溫核酸增幅技術 (INAAT) 市場 – 主要趨勢與促進因素總結

為什麼恒溫核酸增幅技術 (INAAT) 會徹底改變分子診斷？

恒溫核酸增幅技術（INAAT）透過提供不需要熱感的快速、靈敏、特異性的核酸檢測方法正在徹底改變分子診斷領域。與傳統 PCR 技術不同，INAAT 在恆溫下運行，簡化了所需設備並縮短了獲得結果的時間。該技術在快速、準確的診斷至關重要的照護端環境中特別有用。 INAAT 已廣泛應用於感染疾病、遺傳疾病和癌症生物標記的檢測，使其成為現代醫療保健的重要工具。 INAAT 能夠快速、高精度地產生結果，使其在常規臨床診斷中得到越來越多的採用，特別是在資源匱乏、先進測試基礎設施訪問有限的環境中。

科技進步如何增強 INAAT 的能力？

技術進步顯著增強了 INAAT 的功能，使其更加強大、多功能且易於使用。酵素設計和反應化學方面的創新提高了 INAAT 檢測的靈敏度和特異性，使其能夠檢測複雜生物樣品中的低水平核酸。此外，結合 INAAT 的可攜式、易於使用的設備的開發擴大了其在現場診斷和家庭測試中的用途。這些進步對於對抗新出現的感染疾病特別有影響力，其中快速和分散的檢測至關重要。此外，INAAT 與數位技術和資料分析的集合成為即時監測疾病爆發和個人化醫療開闢了新的可能性。這些技術進步正在推動 INAAT 在從公共衛生到個人化醫療等各個領域的採用。

INAAT市場存在哪些挑戰與機會？

儘管 INAAT 的應用日益廣泛，但 INAAT 市場仍面臨多項挑戰，包括標準化需求、監管障礙以及現有分子診斷技術的競爭。不同 INAAT 平台之間缺乏標準化方案和試劑可能會導致結果差異，這是臨床應用的問題。此外，診斷測試的嚴格監管要求可能會延遲新 INAAT 產品的商業化，特別是在美國和歐洲等監管嚴格的市場。然而，這些挑戰也帶來了創新和市場成長的機會。能夠開發標準化、易於使用的 INAAT套件並獲得廣泛監管核准的公司將能夠利用快速診斷不斷成長的需求。此外，感染疾病控制、癌症篩檢和個人化醫療等領域對改進診斷工具的持續需求繼續推動人們對 INAAT 的興趣和投資。

推動INAAT市場成長的因素有哪些？

恒溫核酸增幅技術（INAAT）市場的成長受到多種因素的推動，例如對快速且準確診斷的需求不斷增加、感染疾病的流行以及分子生物學的進步。對就地檢驗的需求不斷成長，特別是在 COVID-19 大流行等全球健康危機中，凸顯了快速可靠的診斷工具的重要性，推動了 INAAT I am 的採用。此外，INAAT 應用擴展到傳染病檢查之外，例如腫瘤學和基因檢測，也有助於市場成長。提高 INAAT 平台性能和易用性的技術進步也發揮了關鍵作用，使其能夠在從臨床實驗室到偏遠地區的各種環境中廣泛採用。隨著醫療保健系統不斷強調早期診斷和個人化治療的重要性，對 INAAT 的需求預計將成長，從而推動進一步的進步和市場擴張。

受訪企業範例（12家知名企業）

  • Becton, Dickinson and Company
  • bioMerieux SA
  • Eiken Chemical Co., Ltd.
  • Lucigen Corporation
  • Meridian Bioscience, Inc.
  • Nugen Audio
  • QIAGEN GmbH
  • Ustar Biotechnologies（Hangzhou）Ltd.

目錄

第1章調查方法

第 2 章執行摘要

  • 市場概況
  • 主要企業
  • 市場趨勢和促進因素
  • 全球市場展望

第3章市場分析

  • 美國
  • 加拿大
  • 日本
  • 中國
  • 歐洲
  • 法國
  • 德國
  • 義大利
  • 英國
  • 其他歐洲國家
  • 亞太地區
  • 其他領域

第4章 比賽

簡介目錄
Product Code: MCP12875

Global Isothermal Nucleic Acid Amplification Technology (INAAT) Market to Reach US$6.7 Billion by 2030

The global market for Isothermal Nucleic Acid Amplification Technology (INAAT) estimated at US$3.4 Billion in the year 2023, is expected to reach US$6.7 Billion by 2030, growing at a CAGR of 10.3% over the analysis period 2023-2030. INAAT Reagents, one of the segments analyzed in the report, is expected to record a 10.1% CAGR and reach US$4.6 Billion by the end of the analysis period. Growth in the INAAT Instruments segment is estimated at 10.7% CAGR over the analysis period.

The U.S. Market is Estimated at US$898.3 Million While China is Forecast to Grow at 9.7% CAGR

The Isothermal Nucleic Acid Amplification Technology (INAAT) market in the U.S. is estimated at US$898.3 Million in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$1.0 Billion by the year 2030 trailing a CAGR of 9.7% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 9.2% and 8.6% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 8.0% CAGR.

Global Isothermal Nucleic Acid Amplification Technology (INAAT) Market - Key Trends & Drivers Summarized

Why Is Isothermal Nucleic Acid Amplification Technology (INAAT) Revolutionizing Molecular Diagnostics?

Isothermal Nucleic Acid Amplification Technology (INAAT) is revolutionizing the field of molecular diagnostics by providing a rapid, sensitive, and specific method for detecting nucleic acids without the need for thermal cycling. Unlike traditional PCR techniques, INAAT operates at a constant temperature, simplifying the equipment required and reducing the time to results. This technology is particularly valuable in point-of-care settings, where quick and accurate diagnostics are essential. INAAT is being widely adopted for the detection of infectious diseases, genetic disorders, and cancer biomarkers, making it an indispensable tool in modern healthcare. The technology's ability to deliver results quickly and with high accuracy is driving its integration into routine clinical diagnostics, especially in resource-limited settings where access to sophisticated laboratory infrastructure is limited.

How Are Technological Advancements Enhancing the Capabilities of INAAT?

Technological advancements are significantly enhancing the capabilities of INAAT, making it more robust, versatile, and accessible. Innovations in enzyme design and reaction chemistry are improving the sensitivity and specificity of INAAT assays, enabling the detection of low levels of nucleic acids in complex biological samples. Additionally, the development of portable and user-friendly devices that incorporate INAAT is expanding its use in field diagnostics and at-home testing. These advancements are particularly impactful in the fight against emerging infectious diseases, where rapid and decentralized testing is critical. The integration of INAAT with digital technologies and data analytics is also opening new possibilities for real-time monitoring of disease outbreaks and personalized medicine. These technological improvements are driving the adoption of INAAT across various sectors, from public health to personalized medicine.

What Challenges and Opportunities Exist in the INAAT Market?

Despite its growing adoption, the INAAT market faces several challenges, including the need for greater standardization, regulatory hurdles, and competition from established molecular diagnostics technologies. The lack of standardized protocols and reagents across different INAAT platforms can lead to variability in results, which is a concern for clinical applications. Additionally, the stringent regulatory requirements for diagnostic tests can slow down the commercialization of new INAAT products, particularly in highly regulated markets like the United States and Europe. However, these challenges also present opportunities for innovation and market growth. Companies that can develop standardized, easy-to-use INAAT kits with broad regulatory approval will be well-positioned to capitalize on the growing demand for rapid diagnostics. Moreover, the ongoing need for improved diagnostic tools in areas such as infectious disease control, cancer screening, and personalized medicine continues to drive interest and investment in INAAT.

What Factors Are Driving Growth in the INAAT Market?

The growth in the Isothermal Nucleic Acid Amplification Technology (INAAT) market is driven by several factors, including the increasing demand for rapid and accurate diagnostics, the rising prevalence of infectious diseases, and advancements in molecular biology. The ongoing need for point-of-care testing, particularly in the context of global health crises like the COVID-19 pandemic, has highlighted the importance of quick and reliable diagnostic tools, boosting the adoption of INAAT. Additionally, the expansion of INAAT applications beyond infectious disease testing, such as in oncology and genetic testing, is contributing to market growth. Technological advancements that improve the performance and ease of use of INAAT platforms are also playing a crucial role, as they enable wider adoption across different settings, from clinical laboratories to remote locations. As healthcare systems continue to emphasize the importance of early diagnosis and personalized treatment, the demand for INAAT is expected to grow, driving further advancements and market expansion.

Select Competitors (Total 12 Featured) -

  • Becton, Dickinson and Company
  • bioMerieux SA
  • Eiken Chemical Co., Ltd.
  • Lucigen Corporation
  • Meridian Bioscience, Inc.
  • Nugen Audio
  • QIAGEN GmbH
  • Ustar Biotechnologies (Hangzhou) Ltd.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Global Isothermal Nucleic Acid Amplification Technology (INAAT) Market to Witness Healthy Growth, Driven by Low-cost Advantages
    • Isothermal Nucleic Acid Amplification Technology (INAAT) - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
    • Global Economic Update
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Demand for Rapid Diagnostics Spurs Growth in INAAT Market
    • Advancements in Molecular Biology Propel Innovation in INAAT Applications
    • Growing Use of INAAT in Point-of-Care Testing Expands Addressable Market
    • Shift Towards Decentralized and Home-Based Testing Strengthens Business Case for INAAT
    • Increased Focus on Early Detection of Infectious Diseases Drives Adoption of INAAT
    • Technological Innovations in Isothermal Amplification Accelerate Market Growth
    • Rising Need for Portable and User-Friendly Diagnostic Tools Throws Spotlight on INAAT
    • Expanding Applications of INAAT in Oncology and Genetic Testing Generate New Opportunities
    • Shift Towards Personalized Medicine Drives Innovation in INAAT Applications
    • Rising Demand for Temperature-Sensitive Logistics Spurs Growth in Isothermal Packaging Market
    • Advancements in Insulation Materials Propel Innovation in Isothermal Packaging
    • Growing Use of Isothermal Packaging in Pharmaceutical and Biotechnology Expands Addressable Market
    • Shift Towards Sustainable Packaging Solutions Strengthens Business Case for Isothermal Packaging
    • Increased Focus on Cold Chain Integrity Drives Adoption of Isothermal Packaging
    • Technological Innovations in Passive and Active Cooling Systems Accelerate Market Growth
    • Rising Need for Safe Vaccine Distribution Throws Spotlight on Isothermal Packaging
    • Expanding Applications of Isothermal Packaging in Food and Beverage Industry Generate New Opportunities
    • Shift Towards E-commerce and Direct-to-Consumer Deliveries Drives Demand for Isothermal Packaging
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Blood Screening by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 2: World Historic Review for Blood Screening by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 3: World 16-Year Perspective for Blood Screening by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 5: World Historic Review for Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 6: World 16-Year Perspective for Instruments by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Reagents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 8: World Historic Review for Reagents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 9: World 16-Year Perspective for Reagents by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 11: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 12: World 16-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 13: World Isothermal Nucleic Acid Amplification Technology (INAAT) Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Isothermal Nucleic Acid Amplification Technology (INAAT) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Isothermal Nucleic Acid Amplification Technology (INAAT) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 16: World 16-Year Perspective for Isothermal Nucleic Acid Amplification Technology (INAAT) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2014, 2024 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Infectious Disease Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Infectious Disease Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 19: World 16-Year Perspective for Infectious Disease Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Cancer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Cancer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 22: World 16-Year Perspective for Cancer by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 25: World 16-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 28: World 16-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 29: World Recent Past, Current & Future Analysis for Central & Reference Labs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 30: World Historic Review for Central & Reference Labs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 31: World 16-Year Perspective for Central & Reference Labs by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Isothermal Nucleic Acid Amplification Technology (INAAT) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • Active Players in United States
    • TABLE 32: USA Recent Past, Current & Future Analysis for Isothermal Nucleic Acid Amplification Technology (INAAT) by Application - Infectious Disease Diagnostics, Blood Screening, Cancer and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 33: USA Historic Review for Isothermal Nucleic Acid Amplification Technology (INAAT) by Application - Infectious Disease Diagnostics, Blood Screening, Cancer and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 34: USA 16-Year Perspective for Isothermal Nucleic Acid Amplification Technology (INAAT) by Application - Percentage Breakdown of Value Sales for Infectious Disease Diagnostics, Blood Screening, Cancer and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 35: USA Recent Past, Current & Future Analysis for Isothermal Nucleic Acid Amplification Technology (INAAT) by Product - Reagents and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 36: USA Historic Review for Isothermal Nucleic Acid Amplification Technology (INAAT) by Product - Reagents and Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 37: USA 16-Year Perspective for Isothermal Nucleic Acid Amplification Technology (INAAT) by Product - Percentage Breakdown of Value Sales for Reagents and Instruments for the Years 2014, 2024 & 2030
    • TABLE 38: USA Recent Past, Current & Future Analysis for Isothermal Nucleic Acid Amplification Technology (INAAT) by End-Use - Hospitals, Central & Reference Labs and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 39: USA Historic Review for Isothermal Nucleic Acid Amplification Technology (INAAT) by End-Use - Hospitals, Central & Reference Labs and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 40: USA 16-Year Perspective for Isothermal Nucleic Acid Amplification Technology (INAAT) by End-Use - Percentage Breakdown of Value Sales for Hospitals, Central & Reference Labs and Other End-Uses for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 41: Canada Recent Past, Current & Future Analysis for Isothermal Nucleic Acid Amplification Technology (INAAT) by Application - Infectious Disease Diagnostics, Blood Screening, Cancer and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 42: Canada Historic Review for Isothermal Nucleic Acid Amplification Technology (INAAT) by Application - Infectious Disease Diagnostics, Blood Screening, Cancer and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 43: Canada 16-Year Perspective for Isothermal Nucleic Acid Amplification Technology (INAAT) by Application - Percentage Breakdown of Value Sales for Infectious Disease Diagnostics, Blood Screening, Cancer and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 44: Canada Recent Past, Current & Future Analysis for Isothermal Nucleic Acid Amplification Technology (INAAT) by Product - Reagents and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 45: Canada Historic Review for Isothermal Nucleic Acid Amplification Technology (INAAT) by Product - Reagents and Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 46: Canada 16-Year Perspective for Isothermal Nucleic Acid Amplification Technology (INAAT) by Product - Percentage Breakdown of Value Sales for Reagents and Instruments for the Years 2014, 2024 & 2030
    • TABLE 47: Canada Recent Past, Current & Future Analysis for Isothermal Nucleic Acid Amplification Technology (INAAT) by End-Use - Hospitals, Central & Reference Labs and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 48: Canada Historic Review for Isothermal Nucleic Acid Amplification Technology (INAAT) by End-Use - Hospitals, Central & Reference Labs and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 49: Canada 16-Year Perspective for Isothermal Nucleic Acid Amplification Technology (INAAT) by End-Use - Percentage Breakdown of Value Sales for Hospitals, Central & Reference Labs and Other End-Uses for the Years 2014, 2024 & 2030
  • JAPAN
    • Isothermal Nucleic Acid Amplification Technology (INAAT) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • Active Players in Japan
    • TABLE 50: Japan Recent Past, Current & Future Analysis for Isothermal Nucleic Acid Amplification Technology (INAAT) by Application - Infectious Disease Diagnostics, Blood Screening, Cancer and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 51: Japan Historic Review for Isothermal Nucleic Acid Amplification Technology (INAAT) by Application - Infectious Disease Diagnostics, Blood Screening, Cancer and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 52: Japan 16-Year Perspective for Isothermal Nucleic Acid Amplification Technology (INAAT) by Application - Percentage Breakdown of Value Sales for Infectious Disease Diagnostics, Blood Screening, Cancer and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 53: Japan Recent Past, Current & Future Analysis for Isothermal Nucleic Acid Amplification Technology (INAAT) by Product - Reagents and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 54: Japan Historic Review for Isothermal Nucleic Acid Amplification Technology (INAAT) by Product - Reagents and Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 55: Japan 16-Year Perspective for Isothermal Nucleic Acid Amplification Technology (INAAT) by Product - Percentage Breakdown of Value Sales for Reagents and Instruments for the Years 2014, 2024 & 2030
    • TABLE 56: Japan Recent Past, Current & Future Analysis for Isothermal Nucleic Acid Amplification Technology (INAAT) by End-Use - Hospitals, Central & Reference Labs and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 57: Japan Historic Review for Isothermal Nucleic Acid Amplification Technology (INAAT) by End-Use - Hospitals, Central & Reference Labs and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 58: Japan 16-Year Perspective for Isothermal Nucleic Acid Amplification Technology (INAAT) by End-Use - Percentage Breakdown of Value Sales for Hospitals, Central & Reference Labs and Other End-Uses for the Years 2014, 2024 & 2030
  • CHINA
    • Isothermal Nucleic Acid Amplification Technology (INAAT) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • Active Players in China
    • TABLE 59: China Recent Past, Current & Future Analysis for Isothermal Nucleic Acid Amplification Technology (INAAT) by Application - Infectious Disease Diagnostics, Blood Screening, Cancer and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 60: China Historic Review for Isothermal Nucleic Acid Amplification Technology (INAAT) by Application - Infectious Disease Diagnostics, Blood Screening, Cancer and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 61: China 16-Year Perspective for Isothermal Nucleic Acid Amplification Technology (INAAT) by Application - Percentage Breakdown of Value Sales for Infectious Disease Diagnostics, Blood Screening, Cancer and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 62: China Recent Past, Current & Future Analysis for Isothermal Nucleic Acid Amplification Technology (INAAT) by Product - Reagents and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 63: China Historic Review for Isothermal Nucleic Acid Amplification Technology (INAAT) by Product - Reagents and Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 64: China 16-Year Perspective for Isothermal Nucleic Acid Amplification Technology (INAAT) by Product - Percentage Breakdown of Value Sales for Reagents and Instruments for the Years 2014, 2024 & 2030
    • TABLE 65: China Recent Past, Current & Future Analysis for Isothermal Nucleic Acid Amplification Technology (INAAT) by End-Use - Hospitals, Central & Reference Labs and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 66: China Historic Review for Isothermal Nucleic Acid Amplification Technology (INAAT) by End-Use - Hospitals, Central & Reference Labs and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 67: China 16-Year Perspective for Isothermal Nucleic Acid Amplification Technology (INAAT) by End-Use - Percentage Breakdown of Value Sales for Hospitals, Central & Reference Labs and Other End-Uses for the Years 2014, 2024 & 2030
  • EUROPE
    • Isothermal Nucleic Acid Amplification Technology (INAAT) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 68: Europe Recent Past, Current & Future Analysis for Isothermal Nucleic Acid Amplification Technology (INAAT) by Application - Infectious Disease Diagnostics, Blood Screening, Cancer and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 69: Europe Historic Review for Isothermal Nucleic Acid Amplification Technology (INAAT) by Application - Infectious Disease Diagnostics, Blood Screening, Cancer and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 70: Europe 16-Year Perspective for Isothermal Nucleic Acid Amplification Technology (INAAT) by Application - Percentage Breakdown of Value Sales for Infectious Disease Diagnostics, Blood Screening, Cancer and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 71: Europe Recent Past, Current & Future Analysis for Isothermal Nucleic Acid Amplification Technology (INAAT) by Product - Reagents and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 72: Europe Historic Review for Isothermal Nucleic Acid Amplification Technology (INAAT) by Product - Reagents and Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 73: Europe 16-Year Perspective for Isothermal Nucleic Acid Amplification Technology (INAAT) by Product - Percentage Breakdown of Value Sales for Reagents and Instruments for the Years 2014, 2024 & 2030
    • TABLE 74: Europe Recent Past, Current & Future Analysis for Isothermal Nucleic Acid Amplification Technology (INAAT) by End-Use - Hospitals, Central & Reference Labs and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 75: Europe Historic Review for Isothermal Nucleic Acid Amplification Technology (INAAT) by End-Use - Hospitals, Central & Reference Labs and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 76: Europe 16-Year Perspective for Isothermal Nucleic Acid Amplification Technology (INAAT) by End-Use - Percentage Breakdown of Value Sales for Hospitals, Central & Reference Labs and Other End-Uses for the Years 2014, 2024 & 2030
    • TABLE 77: Europe Recent Past, Current & Future Analysis for Isothermal Nucleic Acid Amplification Technology (INAAT) by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 78: Europe Historic Review for Isothermal Nucleic Acid Amplification Technology (INAAT) by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 79: Europe 16-Year Perspective for Isothermal Nucleic Acid Amplification Technology (INAAT) by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2014, 2024 & 2030
  • FRANCE
    • Isothermal Nucleic Acid Amplification Technology (INAAT) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • Active Players in France
    • TABLE 80: France Recent Past, Current & Future Analysis for Isothermal Nucleic Acid Amplification Technology (INAAT) by Application - Infectious Disease Diagnostics, Blood Screening, Cancer and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 81: France Historic Review for Isothermal Nucleic Acid Amplification Technology (INAAT) by Application - Infectious Disease Diagnostics, Blood Screening, Cancer and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 82: France 16-Year Perspective for Isothermal Nucleic Acid Amplification Technology (INAAT) by Application - Percentage Breakdown of Value Sales for Infectious Disease Diagnostics, Blood Screening, Cancer and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 83: France Recent Past, Current & Future Analysis for Isothermal Nucleic Acid Amplification Technology (INAAT) by Product - Reagents and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 84: France Historic Review for Isothermal Nucleic Acid Amplification Technology (INAAT) by Product - Reagents and Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 85: France 16-Year Perspective for Isothermal Nucleic Acid Amplification Technology (INAAT) by Product - Percentage Breakdown of Value Sales for Reagents and Instruments for the Years 2014, 2024 & 2030
    • TABLE 86: France Recent Past, Current & Future Analysis for Isothermal Nucleic Acid Amplification Technology (INAAT) by End-Use - Hospitals, Central & Reference Labs and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 87: France Historic Review for Isothermal Nucleic Acid Amplification Technology (INAAT) by End-Use - Hospitals, Central & Reference Labs and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 88: France 16-Year Perspective for Isothermal Nucleic Acid Amplification Technology (INAAT) by End-Use - Percentage Breakdown of Value Sales for Hospitals, Central & Reference Labs and Other End-Uses for the Years 2014, 2024 & 2030
  • GERMANY
    • Isothermal Nucleic Acid Amplification Technology (INAAT) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • Active Players in Germany
    • TABLE 89: Germany Recent Past, Current & Future Analysis for Isothermal Nucleic Acid Amplification Technology (INAAT) by Application - Infectious Disease Diagnostics, Blood Screening, Cancer and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 90: Germany Historic Review for Isothermal Nucleic Acid Amplification Technology (INAAT) by Application - Infectious Disease Diagnostics, Blood Screening, Cancer and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 91: Germany 16-Year Perspective for Isothermal Nucleic Acid Amplification Technology (INAAT) by Application - Percentage Breakdown of Value Sales for Infectious Disease Diagnostics, Blood Screening, Cancer and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 92: Germany Recent Past, Current & Future Analysis for Isothermal Nucleic Acid Amplification Technology (INAAT) by Product - Reagents and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 93: Germany Historic Review for Isothermal Nucleic Acid Amplification Technology (INAAT) by Product - Reagents and Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 94: Germany 16-Year Perspective for Isothermal Nucleic Acid Amplification Technology (INAAT) by Product - Percentage Breakdown of Value Sales for Reagents and Instruments for the Years 2014, 2024 & 2030
    • TABLE 95: Germany Recent Past, Current & Future Analysis for Isothermal Nucleic Acid Amplification Technology (INAAT) by End-Use - Hospitals, Central & Reference Labs and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 96: Germany Historic Review for Isothermal Nucleic Acid Amplification Technology (INAAT) by End-Use - Hospitals, Central & Reference Labs and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 97: Germany 16-Year Perspective for Isothermal Nucleic Acid Amplification Technology (INAAT) by End-Use - Percentage Breakdown of Value Sales for Hospitals, Central & Reference Labs and Other End-Uses for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 98: Italy Recent Past, Current & Future Analysis for Isothermal Nucleic Acid Amplification Technology (INAAT) by Application - Infectious Disease Diagnostics, Blood Screening, Cancer and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 99: Italy Historic Review for Isothermal Nucleic Acid Amplification Technology (INAAT) by Application - Infectious Disease Diagnostics, Blood Screening, Cancer and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 100: Italy 16-Year Perspective for Isothermal Nucleic Acid Amplification Technology (INAAT) by Application - Percentage Breakdown of Value Sales for Infectious Disease Diagnostics, Blood Screening, Cancer and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 101: Italy Recent Past, Current & Future Analysis for Isothermal Nucleic Acid Amplification Technology (INAAT) by Product - Reagents and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 102: Italy Historic Review for Isothermal Nucleic Acid Amplification Technology (INAAT) by Product - Reagents and Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 103: Italy 16-Year Perspective for Isothermal Nucleic Acid Amplification Technology (INAAT) by Product - Percentage Breakdown of Value Sales for Reagents and Instruments for the Years 2014, 2024 & 2030
    • TABLE 104: Italy Recent Past, Current & Future Analysis for Isothermal Nucleic Acid Amplification Technology (INAAT) by End-Use - Hospitals, Central & Reference Labs and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 105: Italy Historic Review for Isothermal Nucleic Acid Amplification Technology (INAAT) by End-Use - Hospitals, Central & Reference Labs and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 106: Italy 16-Year Perspective for Isothermal Nucleic Acid Amplification Technology (INAAT) by End-Use - Percentage Breakdown of Value Sales for Hospitals, Central & Reference Labs and Other End-Uses for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • Isothermal Nucleic Acid Amplification Technology (INAAT) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • Active Players in United Kingdom
    • TABLE 107: UK Recent Past, Current & Future Analysis for Isothermal Nucleic Acid Amplification Technology (INAAT) by Application - Infectious Disease Diagnostics, Blood Screening, Cancer and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 108: UK Historic Review for Isothermal Nucleic Acid Amplification Technology (INAAT) by Application - Infectious Disease Diagnostics, Blood Screening, Cancer and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 109: UK 16-Year Perspective for Isothermal Nucleic Acid Amplification Technology (INAAT) by Application - Percentage Breakdown of Value Sales for Infectious Disease Diagnostics, Blood Screening, Cancer and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 110: UK Recent Past, Current & Future Analysis for Isothermal Nucleic Acid Amplification Technology (INAAT) by Product - Reagents and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 111: UK Historic Review for Isothermal Nucleic Acid Amplification Technology (INAAT) by Product - Reagents and Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 112: UK 16-Year Perspective for Isothermal Nucleic Acid Amplification Technology (INAAT) by Product - Percentage Breakdown of Value Sales for Reagents and Instruments for the Years 2014, 2024 & 2030
    • TABLE 113: UK Recent Past, Current & Future Analysis for Isothermal Nucleic Acid Amplification Technology (INAAT) by End-Use - Hospitals, Central & Reference Labs and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 114: UK Historic Review for Isothermal Nucleic Acid Amplification Technology (INAAT) by End-Use - Hospitals, Central & Reference Labs and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 115: UK 16-Year Perspective for Isothermal Nucleic Acid Amplification Technology (INAAT) by End-Use - Percentage Breakdown of Value Sales for Hospitals, Central & Reference Labs and Other End-Uses for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 116: Rest of Europe Recent Past, Current & Future Analysis for Isothermal Nucleic Acid Amplification Technology (INAAT) by Application - Infectious Disease Diagnostics, Blood Screening, Cancer and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 117: Rest of Europe Historic Review for Isothermal Nucleic Acid Amplification Technology (INAAT) by Application - Infectious Disease Diagnostics, Blood Screening, Cancer and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 118: Rest of Europe 16-Year Perspective for Isothermal Nucleic Acid Amplification Technology (INAAT) by Application - Percentage Breakdown of Value Sales for Infectious Disease Diagnostics, Blood Screening, Cancer and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 119: Rest of Europe Recent Past, Current & Future Analysis for Isothermal Nucleic Acid Amplification Technology (INAAT) by Product - Reagents and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 120: Rest of Europe Historic Review for Isothermal Nucleic Acid Amplification Technology (INAAT) by Product - Reagents and Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 121: Rest of Europe 16-Year Perspective for Isothermal Nucleic Acid Amplification Technology (INAAT) by Product - Percentage Breakdown of Value Sales for Reagents and Instruments for the Years 2014, 2024 & 2030
    • TABLE 122: Rest of Europe Recent Past, Current & Future Analysis for Isothermal Nucleic Acid Amplification Technology (INAAT) by End-Use - Hospitals, Central & Reference Labs and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 123: Rest of Europe Historic Review for Isothermal Nucleic Acid Amplification Technology (INAAT) by End-Use - Hospitals, Central & Reference Labs and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 124: Rest of Europe 16-Year Perspective for Isothermal Nucleic Acid Amplification Technology (INAAT) by End-Use - Percentage Breakdown of Value Sales for Hospitals, Central & Reference Labs and Other End-Uses for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • Isothermal Nucleic Acid Amplification Technology (INAAT) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 125: Asia-Pacific Recent Past, Current & Future Analysis for Isothermal Nucleic Acid Amplification Technology (INAAT) by Application - Infectious Disease Diagnostics, Blood Screening, Cancer and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 126: Asia-Pacific Historic Review for Isothermal Nucleic Acid Amplification Technology (INAAT) by Application - Infectious Disease Diagnostics, Blood Screening, Cancer and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 127: Asia-Pacific 16-Year Perspective for Isothermal Nucleic Acid Amplification Technology (INAAT) by Application - Percentage Breakdown of Value Sales for Infectious Disease Diagnostics, Blood Screening, Cancer and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 128: Asia-Pacific Recent Past, Current & Future Analysis for Isothermal Nucleic Acid Amplification Technology (INAAT) by Product - Reagents and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 129: Asia-Pacific Historic Review for Isothermal Nucleic Acid Amplification Technology (INAAT) by Product - Reagents and Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 130: Asia-Pacific 16-Year Perspective for Isothermal Nucleic Acid Amplification Technology (INAAT) by Product - Percentage Breakdown of Value Sales for Reagents and Instruments for the Years 2014, 2024 & 2030
    • TABLE 131: Asia-Pacific Recent Past, Current & Future Analysis for Isothermal Nucleic Acid Amplification Technology (INAAT) by End-Use - Hospitals, Central & Reference Labs and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 132: Asia-Pacific Historic Review for Isothermal Nucleic Acid Amplification Technology (INAAT) by End-Use - Hospitals, Central & Reference Labs and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 133: Asia-Pacific 16-Year Perspective for Isothermal Nucleic Acid Amplification Technology (INAAT) by End-Use - Percentage Breakdown of Value Sales for Hospitals, Central & Reference Labs and Other End-Uses for the Years 2014, 2024 & 2030
  • REST OF WORLD
    • TABLE 134: Rest of World Recent Past, Current & Future Analysis for Isothermal Nucleic Acid Amplification Technology (INAAT) by Application - Infectious Disease Diagnostics, Blood Screening, Cancer and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 135: Rest of World Historic Review for Isothermal Nucleic Acid Amplification Technology (INAAT) by Application - Infectious Disease Diagnostics, Blood Screening, Cancer and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 136: Rest of World 16-Year Perspective for Isothermal Nucleic Acid Amplification Technology (INAAT) by Application - Percentage Breakdown of Value Sales for Infectious Disease Diagnostics, Blood Screening, Cancer and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 137: Rest of World Recent Past, Current & Future Analysis for Isothermal Nucleic Acid Amplification Technology (INAAT) by Product - Reagents and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 138: Rest of World Historic Review for Isothermal Nucleic Acid Amplification Technology (INAAT) by Product - Reagents and Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 139: Rest of World 16-Year Perspective for Isothermal Nucleic Acid Amplification Technology (INAAT) by Product - Percentage Breakdown of Value Sales for Reagents and Instruments for the Years 2014, 2024 & 2030
    • TABLE 140: Rest of World Recent Past, Current & Future Analysis for Isothermal Nucleic Acid Amplification Technology (INAAT) by End-Use - Hospitals, Central & Reference Labs and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 141: Rest of World Historic Review for Isothermal Nucleic Acid Amplification Technology (INAAT) by End-Use - Hospitals, Central & Reference Labs and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 142: Rest of World 16-Year Perspective for Isothermal Nucleic Acid Amplification Technology (INAAT) by End-Use - Percentage Breakdown of Value Sales for Hospitals, Central & Reference Labs and Other End-Uses for the Years 2014, 2024 & 2030

IV. COMPETITION